Gilead Sciences delivered a strong first quarter on the surface, but the bigger story is that the business is beginning to transition from a mature HIV-focused cash flow machine into a more diversified growth story — while taking on significantly more execution risk in the process. At the headline level, the quarter was strong. Total…

Airbnb delivered a strong first quarter, but the more important takeaway was not simply that growth accelerated. It was that the business is beginning to show signs of evolving beyond a pure accommodation platform into a broader travel ecosystem, while proving it can remain resilient through macro uncertainty. At the headline level, the quarter was…

The Walt Disney Company reported a solid set of fiscal second quarter 2026 results, reflecting steady progress in its transformation toward a more profitable streaming-led business while maintaining strength in its parks and experiences segment. Revenue increased 7 percent year over year to $25.2 billion, supported by growth across entertainment and experiences, while income before…

Uber’s Q1 2026 results show a company that continues to grow at scale while increasingly converting that growth into profit and cash flow. The platform processed 3.6 billion trips in the quarter, representing a 20 percent year over year increase, supported by a 17 percent rise in monthly active users and a modest increase in…

AMD delivered a very strong quarter, and unlike some AI-related companies where investors are debating whether growth is peaking, this report suggested the opposite. The business is becoming increasingly centred around data centre infrastructure, and that segment is now clearly carrying the company into its next phase of growth. First quarter revenue came in at…

Super Micro Computer delivered a quarter that looked very strong on the surface, but the underlying story is becoming far more nuanced as investors begin shifting their focus from pure growth toward balance sheet quality and cash flow sustainability. The headline revenue number was once again exceptional. SMCI reported third quarter fiscal 2026 revenue of…

Pfizer’s Q1 2026 results were meaningfully stronger than investor sentiment suggests, but the market will likely remain focused on whether its post-COVID transition is truly sustainable. The headline numbers looked solid. Revenue rose 5% year over year to $14.5 billion, while operational growth was 2% after adjusting for foreign exchange. That may not seem impressive…